B&G Foods, Inc.
B&G Foods, Inc. (BGS) Financial Performance & Income Statement Overview
Access detailed quarterly and annual financial reports for B&G Foods, Inc. (BGS), covering cash flow, earnings, and balance sheets.
B&G Foods, Inc. (BGS) Income Statement & Financial Overview
View the income breakdown for B&G Foods, Inc. BGS across both annual and quarterly reports.
Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
---|---|---|---|---|
Revenue | $425.40M | $551.57M | $461.07M | $444.59M |
Cost of Revenue | $335.31M | $432.88M | $358.73M | $352.55M |
Gross Profit | $90.09M | $118.69M | $102.34M | $92.04M |
Gross Profit Ratio | $0.21 | $0.22 | $0.22 | $0.21 |
R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
SG&A Expenses | $49.13M | $50.34M | $45.99M | $43.13M |
Operating Expenses | $54.24M | $375.45M | $51.10M | $48.24M |
Total Costs & Expenses | $389.56M | $808.33M | $409.83M | $400.79M |
Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
Interest Expense | $37.76M | $39.65M | $42.17M | $37.81M |
Depreciation & Amortization | $21.79M | $21.86M | $22.11M | $21.85M |
EBITDA | $58.78M | -$233.64M | $74.41M | $66.69M |
EBITDA Ratio | $0.14 | -$0.42 | $0.16 | $0.15 |
Operating Income | $35.85M | -$256.76M | $51.25M | $43.80M |
Operating Income Ratio | $0.08 | -$0.47 | $0.11 | $0.10 |
Other Income/Expenses (Net) | -$36.61M | -$38.57M | -$41.12M | -$36.76M |
Income Before Tax | -$765000.00 | -$295.33M | $10.13M | $7.04M |
Income Before Tax Ratio | -$0.002 | -$0.54 | $0.02 | $0.02 |
Income Tax Expense | -$1.60M | -$72.92M | $2.66M | $3.10M |
Net Income | $835000.00 | -$222.41M | $7.46M | $3.94M |
Net Income Ratio | $0.002 | -$0.40 | $0.02 | $0.009 |
EPS | $0.01 | -$2.81 | $0.09 | $0.05 |
Diluted EPS | $0.01 | -$2.81 | $0.09 | $0.05 |
Weighted Avg Shares Outstanding | $79.17M | $79.15M | $79.16M | $79.08M |
Weighted Avg Shares Outstanding (Diluted) | $79.67M | $79.15M | $79.40M | $79.39M |
The company's financials show resilient growth, with revenue advancing from $444.59M in Q2 2024 to $425.40M in Q1 2025. Gross profit remained healthy with margins at 21% in Q1 2025 compared to 21% in Q2 2024. Operating income hit $35.85M last quarter, sustaining a consistent 8% margin. Changes in R&D and SG&A spending did not hinder EBITDA, which stood at $58.78M. Net income rose to $835000.00, while earnings per share reached $0.01. Strong cost management and operational efficiency kept profitability intact, underlining the company's stable and competitive market performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan